Acino wins UNDP tender in Ukraine
Friday 13th November 2020
Acino has won the tender of the Ministry of Health of Ukraine (MOH) through the United Nations Development Program in Ukraine (UNDP) for the supply of medicines for children with mental and behavioral disorders, schizophrenia, affective disorders, and hyperkinetic disorders within the terms of additional procurement in accordance with program2019.
Among the 14 Ukrainian and international pharmaceutical companies and distributors that participated, Acino Ukraine offered more favorable terms while fulfilling all UNDP requirements:
· Best value for Money
· Fairness, integrity and transparency
· Effective international competition
Under the terms of the contract, Acino will supply two drugs, Aripiprazole and Levetiracetam, manufactured by its own Pharma Start plant throughout Ukraine in accordance with the distribution of the Ministry of Health of Ukraine.
Acino in Ukraine regularly participates in the tenders of the United Nations International Development Agency, which specializes in development issues and supports strategic capacity-building initiatives aimed at sustainable human development and growth that will benefit everyone. Through partnerships with national, regional and local governments, civil society and the private sector, UNDP supports Ukraine in its efforts to eradicate poverty, build population capacity, ensure equal access to development, preserve the environment and promote democratic governance.
In 2015, UNDP in Ukraine became a partner of the Ministry of Health of Ukraine for the public procurement of medicines, medical devices and health products. UNDP has reshaped the public procurement market for medicines. This initiative has succeeded not only in improving procurement procedures, but also made it more transparent – positively impacting accessibility to certain medicines and allowing new medical products to enter the Ukrainian market for the first time.
According to UNDP, over the past five years, the international agency has saved around UAH 1.7 billion (USD 66 million) in state budget funds, allowing an increase in treatment coverage for patients in Ukraine.
The successful experience of UNDP Ukraine in the procurement of medicines has become an example of best practice in the region, and has been replicated by six countries: Azerbaijan, Kazakhstan, Moldova, Turkmenistan and Uzbekistan, where Acino also operates; and Bosnia and Herzegovina.